Back to calendar
BlossomHill Therapeutics, Inc. (BLSM) Earnings
BLSM reports earnings on Wednesday, September 2, 2026
earnings report
September 2, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.87
Actual EPS: $-0.90
EPS surprise: 2.81%
Company overview
Market Cap$607.7M
PriceUSD 19.83
52-week high20.61
52-week low15.60
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees63